Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mingchen Health CoSZSE:002919 -0.46%87 Piotroski F-Score is 4 as of Aug. 31, 2026, which is 33% below its 10-year median of 6.00. GuruFocus rates SZSE:002919 with a GF Score™ of 87/100 and a GF Value™ of ¥21.02 (Modestly Undervalued). Among 1,923 Consumer Packaged Goods companies, Mingchen Health Co ranks worse than 68.02% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Mingchen Health Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Mingchen Health Co's Piotroski F-Score or its related term are showing as below:
SZSE:002919'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 4
During the past 13 years, the highest Piotroski F-Score of Mingchen Health Co was 8. The lowest was 3. And the median was 6.
Mingchen Health Co (SZSE:002919) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Mingchen Health Co Piotroski F-Score Related Terms
Mingchen Health Co Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Mingchen Health Co's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:002919 vs PG, CL, EL: Piotroski F-Score Comparison
For the Household & Personal Products subindustry, Mingchen Health Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mingchen Health Co Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Mingchen Health Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Mingchen Health Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Mingchen Health Co's current Net Income (TTM) was -18.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Mingchen Health Co's return on assets of this year was -0.01543201. Mingchen Health Co's return on assets of last year was 0.02261132.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Mingchen Health Co's gearing of this year was 0.0127988. Mingchen Health Co's gearing of last year was 0.01183472.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Mingchen Health Co's current ratio of this year was 1.70996496. Mingchen Health Co's current ratio of last year was 1.89975136.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Mingchen Health Co's number of shares in issue this year was 266.845. Mingchen Health Co's number of shares in issue last year was 265.724.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Mingchen Health Co's gross margin of this year was 0.56115902. Mingchen Health Co's gross margin of last year was 0.48261397.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Mingchen Health Co's asset turnover of this year was 1.47086118. Mingchen Health Co's asset turnover of last year was 1.17696532.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
1
+
0
+
1
+
0
+
0
+
0
+
1
+
1
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Mingchen Health Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Mingchen Health Co (SZSE:002919) has a Piotroski F-Score of 4 as of Aug. 31, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Mingchen Health Co and its competitors. This is 33% below median its historical median of 6.00. Over the past decade, Mingchen Health Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Mingchen Health Co ranks #1308 out of 1923 companies in the Consumer Packaged Goods industry, placing it in the top 68%.
Is Mingchen Health Co's Piotroski F-Score too high?
Mingchen Health Co's current Piotroski F-Score of 4 is 33% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Mingchen Health Co's value of 4 is 20% below this industry median. Based on the distribution chart, Mingchen Health Co ranks #1308 out of 1923 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Mingchen Health Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mingchen Health Co's Piotroski F-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Mingchen Health Co ranks #1308 out of 1923 companies for Piotroski F-Score. This places Mingchen Health Co in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Mingchen Health Co's value of 4 is 20% below this benchmark. Historically, Mingchen Health Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Mingchen Health Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,923 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mingchen Health Co's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Mingchen Health Co and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mingchen Health Co's current Piotroski F-Score is 4, which is 33% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mingchen Health Co stock overvalued right now?
Based on GuruFocus' analysis, Mingchen Health Co (SZSE:002919) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.02, compared to a current price of ¥17.41 — trading 17.2% below its estimated fair value. The current Piotroski F-Score is 4, which is 33% below median its 10-year median of 6.00 and 20% below the Consumer Packaged Goods industry median of 5.00. Mingchen Health Co's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Mingchen Health Co (SZSE:002919), the current Piotroski F-Score is 4 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mingchen Health Co (SZSE:002919) Overvalued in 2026?
Based on GuruFocus' analysis, Mingchen Health Co stock appears to be undervalued.
The current stock price of ¥17.41 is trading 17.2% below its estimated GF Value™ of ¥21.02.
GuruFocus considers Mingchen Health Co to be Modestly Undervalued.
Key valuation signals for SZSE:002919:
Piotroski F-Score: 4 (33% below median its 10-year median of 6.00)
GF Value™: ¥21.02 vs. price of ¥17.41 (17.2% below fair value)
Industry Position: 20% below the Consumer Packaged Goods median (#1308 of 1923)
No single metric tells the full story. See the SZSE:002919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mingchen Health Co Ltd manufactures and markets personal healthcare products. It develops, produces, and sells skin and hair care products. The products of the company include Conditioners, Shampoos, Hand sanitizer, Bathing shower gels and Fragrance shower gel.
87GF Score
Get the complete analysis for SZSE:002919
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002919 has been successfully added to your 
